HBI talks to Anuschka Coovadia, CEO at South-Africa based advisory group Usizo Advisory, about payor-provider relationships in Africa and ongoing efforts to improve healthcare coverage.
South Africa’s competition tribunal have officially approved the acquisition of South Africa-based multinational hospital group Mediclinic, but the buyers needed to accept conditions which were less to do with competition, and more to do with the public good.
How is it you can find Coco-Cola in remote villages in Africa, but not much needed healthcare supplies? HBI catches up with Pretty Mubaiwa, South-Africa-based director of corporate affairs at supply-chain expert advisory group the Africa Resource Center (Arc), to find out more.
The pandemic exposed the fragility of supply chains in emerging markets, and their overdependence on international networks. As delegates at the IFC’s conference in Cape Town, South Africa heard last month, there is a renewed appetite in Africa for self-sufficiency and a coordinated shift towards regionalisation.
An increasing number of Japanese investors are looking to invest in African health care. As Africa strives to increase accessibility to care and increase insurance coverage, we speak to an investor who things the Japanese model is a good fit.
Last month, thought leaders from private healthcare systems across the globe gathered in Cape Town, South Africa, to network, share their findings, and consider how emerging markets can become more resilient. HBI was there, and these are our key themes and takeaways.
HBI caught up with Saul Kornik, CEO & Founder at South-Africa-based KENA Health, at IFC’s Global Private Health Conference in Cape Town. KENA has an app which allows patients to talk directly to a nurse, doctor or mental health professional using text, voice or video.
The board of Mediclinic, the South Africa-based multinational hospital giant, have announced they have agreed acquisition terms with the consortium comprised of Remgro, the investment vehicle of the billionaire Rupert family and a long-time Mediclinic shareholder, and the Mediterranean Shipping Company (MSC). They have recommended these terms to shareholders.
South African analysts say the 504p per share, £3.7bn proposed cash offer for Mediclinic International's equity, the South African, Swiss and Middle East hospital group may somewhat undervalue the business. The current offer equates to an enterprise value of £5.88bn. Analysts put the break up value on an enterprise value at between £5.5bn and £6.2bn. HBI reckons the equity alone could be worth £5.2bn.
Integrated care is well worth delivering. Not only can it help to break down the silos which get in the way of efficient healthcare delivery, but some very effective tools can only be used with integration. A panel at HBI 2022 asked: What do firms have to consider before they can deliver it?
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.OkCookies Policy
